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Surfactant functionPulmonary surfactant is a complex lipid–protein mixture whose main function is to reduce the surface tension
at the air–liquid interface of alveoli to minimize the work of breathing. The exact mechanism by which
surfactant monolayers and multilayers are formed and how they lower surface tension to very low values
during lateral compression remains uncertain. We used time-of-ﬂight secondary ion mass spectrometry to
study the lateral organization of lipids and peptide in surfactant preparations ranging in complexity. We show
that we can successfully determine the location of phospholipids, cholesterol and a peptide in surfactant
Langmuir–Blodgett ﬁlms and we can determine the effect of cholesterol and peptide addition. A thorough
understanding of the lateral organization of PS interfacial ﬁlms will aid in our understanding of the role of
each component as well as different lipid–lipid and lipid–protein interactions. This may further our
understanding of pulmonary surfactant function.Institute, 268 Grosvenor St.,
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Pulmonary surfactant (PS) is a complex mixture of lipids and
proteins that is vital for normal breathing. PS is secreted by alveolar
type II cells and composed of approximately 80% phospholipids (PLs),
5%–10% neutral lipids (mostly cholesterol) and 5%–10% proteins. The
major PL is dipalmitoylphosphatidylcholine (DPPC, 30%–45%). Other
major components are unsaturated phosphatidylcholines (PC, 25%–
35%) and phosphatidylglycerol (PG) [1]. Four surfactant proteins are
present: SP-A, SP-B, SP-C and SP-D which have been found to be
important in PS assembly and function [2–4]. SP-A and SP-D are
hydrophilic proteins that play a role in transport and storage of PS and
in host defense [5]. SP-B and SP-C are hydrophobic proteins that are
essential for the biophysical properties of PS such as insertion of
phospholipids into monolayers and effective ﬁlm organization [6]. PS
forms a surface active ﬁlm at the air–water interface of alveoli whereit lowers the surface tension. As a result, it prevents alveolar collapse
at low lung volumes and lowers the work of breathing [7–9].
Deﬁciency or dysfunction of PS leads to fatal respiratory disorders
such as neonatal respiratory distress syndrome (NRDS) in premature
born babies [10] and acute respiratory distress syndrome (ARDS) in
children and adults [11]. Clinical surfactant preparations, such as
bovine lipid extract surfactant (BLES), are effective in treating NRDS
[12] but have proven less effective in treating or ameliorating ARDS
[13,14]. Considerable research has been devoted in the past few
decades to understand the role of different lipid and protein
components of PS. Such investigation should enable us to better
understand surfactant function and the changes that occur when PS
becomes dysfunctional. This may ultimately aid in preparing more
effective therapeutic surfactants.
For many years, surfactant function was explained by the squeeze-
out model. It proposed that the ﬂuid non-DPPC components, which
are less effective at lowering surface tension, are selectively squeezed
out of the ﬁlm during compression generating a monolayer enriched
in the gel phase lipid DPPC at the air–liquid interface of alveoli
[8,15,16]. More recent studies provide evidence that a solid, liquid
condensed (LC) phase of DPPC is not absolutely necessary to attain
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20]. Moreover, recent studies using electron microscopy [21,22],
atomic force microscopy [23,24], autoradiography [25] and captive
bubble tensiometry [22,26] suggest that this surface active ﬁlm
is not composed of a monolayer. Rather, it consists of a surface
monolayer plus, in some places, one or more lipid bilayers.
These multilayer stacks act as a surface-associated surfactant
reservoir that allow surfactant to be re-inserted into the ﬁlm as
surface pressure is lowered on inspiration [26]. Although much effort
has been put into understanding how surfactant functions, there
is still a lot of uncertainty about the exact mechanism by which
surfactant monolayers and multilayers are formed and how they
lower surface tension to very low values during lateral compression
of PS ﬁlms.
One technique that may assist in further understanding surfactant
function is time-of-ﬂight secondary ion mass spectrometry (ToF-
SIMS). This technique can provide information regarding the lateral
organization of lipids and peptides in Langmuir–Blodgett (LB) ﬁlms of
natural surfactant and surfactant model systems. Brieﬂy, ToF-SIMS
operates by bombarding a sharply focused primary ion beam onto
the surface of a sample which induces a collision cascade among
the target atoms. This leads to desorption of neutral and ionized
species from the surface of the sample. Ionized species are
collected and analyzed by a time-of-ﬂight mass spectrometer. In
imagingmode, the beam is rastered over the surface of the sample and
a full spectrum is collected at each pixel. Thus, a chemical map can
be generated showing the lateral distribution of components in a
mixture [27].
Based on this information, the objective was to perform proof-of-
principle experiments to examine the potential of ToF-SIMS to study
the lateral organization of pulmonary surfactant ﬁlms. To perform
these experiments, we studied various surfactant preparations
ranging in complexity: from three simple PL mixtures to natural
surfactant obtained from the injured lungs of mechanically ventilated
rats and from normal lungs obtained from non-ventilated rats. We
show that we can successfully image and therefore determine the
location of individual PLs, cholesterol and a peptide in interfacial ﬁlms
of these samples. This provides information about phase separation in
these systems as well as effect of cholesterol and peptide addition.
Also, we show that we can detect changes in lateral organization of PS
when it becomes dysfunctional. A thorough understanding of the
lateral organization of PS interfacial ﬁlms will aid in our understand-
ing of the role of each component as well as different lipid–lipid and
lipid–protein interactions. This could provide key pieces to the PS
function mechanism puzzle as well as have broader implications in
more general membrane studies.2. Materials and methods
2.1. Materials
BLES was a generous gift from the manufacturer (BLES Biochem-
icals, London, Ontario, Canada) and was extracted before use using a
modiﬁed Bligh and Dyer technique [28]. Phospholipids and deuter-
ated phospholipids were obtained from Avanti Polar Lipids (Birming-
ham, AL, USA). Cholesterol was obtained from Sigma (St. Louis,
MO, USA) and deuterated-cholesterol was obtained from CDN
Isotopes (Pointe Claire, Quebec, Canada). All were received as
powders and were dissolved in chloroform at a concentration of
1 mg/mL. miniB is a 34-residue peptide with internal disulﬁde
linkages that is composed of the N- and C-terminal helical regions
of SP-B. miniB was isotopically enhanced, synthesized, oxidized-
folded and puriﬁed as described previously [29]. It has been shown
to retain similar activity to full-length SP-B in certain in vitro and in
vivo studies [29].2.2. Rat surfactant isolation
Sprague–Dawley rats (Charles River, St. Constant, PQ, Canada),
weighing 350–430 g were acclimatized for a minimum of 3 days with
free access to water and standard rodent chow. The ventilation
experiments were performed as described previously [30]. Alterations
to surfactant precede physiological deterioration during high tidal
volume ventilation. Brieﬂy, animals received anesthetic (75 mg/kg
Ketamine and 5 mg/kg Xylazine in sterile 0.15 M NaCl) and analgesic
(0.05–0.1 mg/kg Buprenorphrine) followed by cannulation of both
jugular veins and the right carotid artery. Subsequently, the trachea
was exposed and a 14-gauge endotracheal tube was inserted and
secured using 2-0 surgical silk. After the tracheotomy, an intravenous
injection of a neuromuscular inhibitor (2 mg/kg Pancuronium
Bromide) was given to stop spontaneous breathing activity. The
animal was immediately connected to a volume-cycled rodent
ventilator (Harvard Instruments, St. Laurent, PQ, Canada) and after a
stabilization period was ventilated with 100% oxygen using a high
tidal volume (high Vt) ventilation strategy (Vt=30 mL/kg, positive-
end-expiratory pressure=0 cm H2O, at 15–17 breaths per minute).
Peak inspiratory pressure was monitored throughout ventilation and
arterial blood samples for blood gas measurements were taken at
baseline (BL) and every 15 min thereafter.
Following the 2 hours of ventilation, the animals were sacriﬁced
with an overdose of sodium pentobarbital (0.2–0.6 mL 65 mg/mL)
administered intravenously to lower blood pressure and exsangui-
nated via transection of the descending aorta. A midline sternectomy
was performed to expose and visualize the lungs. A non-ventilated
control group of rats were killed in a similar fashion and used to obtain
normal rat surfactant samples. For animals from both groups, a whole
lung lavage procedure was performed as previously described [31].
Brieﬂy, 5×10 mL volumes of sterile 0.15 M saline solution were
infused and withdrawn from the lungs three times each and the
combined lavage volume was centrifuged at 150g for 10 min to
remove cellular debris. The remaining supernatant was centrifuged at
40,000g for 15 min to isolate the pellet containing the large aggregate
(LA) subfraction of surfactant which was resuspended in 2 mL of
0.15 M sterile saline and subsequently extracted by the method of
Bligh and Dyer. All procedures were approved by the animal use sub-
committee at the University of Western Ontario, under the guidelines
of the Canadian Council of Animal Care.
2.3. Langmuir–Blodgett (LB) ﬁlm preparation
A Kibron μTrough SE (Helsinki, Finland) was used to prepare the LB
ﬁlms. The Langmuir balance is equippedwith a continuous teﬂon ribbon
tominimizeﬁlm leakage. The trough contains ~90 mL subphase and has
a working area of ~125 cm2. All samples were dissolved in chloroform
and were spread drop-wise on room-temperature Millipore puriﬁed
water. At least 10 min was allowed before compression for the solvent
to evaporate and for the ﬁlm to equilibrate. The ﬁlms were then
compressed at a rate of 0.02 nm2 molecule−1 min−1 in constant
pressure mode to the desired surface pressure of 30 mN/m. Monolayer
ﬁlms were deposited onto substrates by elevating the previously
submerged substrates vertically through the air–water interface at a
rate of 2.0 mm/min. Gold-coated mica was used as the substrate in all
experiments. Gold-coating was achieved by inserting freshly cleaved
1×1 cm2 pieces of mica into a Hummer VI sputtering system (Technics
EM, Springﬁeld, VA) under reduced pressure at 100 mTorr. The Au was
sputtered onto the substrate for 10 min at a plate current of 10 mA.
Deposited ﬁlms were imaged within 2 hours of deposition.
2.4. Time-of-ﬂight secondary ion mass spectrometry (ToF-SIMS) imaging
ToF-SIMS images were collected using an ION-TOF ToF-SIMS IV
(ION-TOF, Munster, Germany) equipped with a bismuth liquid ion
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University of Western Ontario. The primary analysis beamwas 25 keV
Bi3+ operated in burst alignment mode with 10 kHz repetition rate
and a pulse width of 100 ns. The target current was b0.2 pA and the
spot size was estimated to be ~300 nm. Mass analysis was performed
via a single stage reﬂectron ToF analyzer at 2 keV with 10 keV post
acceleration. The mass range was 0–800 amu with unit mass
resolution. Negative secondary ion images were acquired from
regions of interest, typically with a 50×50 μm2 primary beam raster
size. A 256×256 pixel image resolution was chosen, given the beam
spot size and the raster area used in this work. The negative secondary
ion images of interest were reconstructed from the raw data stream.
Each image is normalized in intensity according to the minimum and
maximum counts in a single pixel; these values are then mapped to a
256 increment, thermal color scale. The thermal gradient is chosen
such that brighter areas in an image correspond to areas of increased
secondary ion yield. In some cases, the ToF-SIMS images were
processed to enhance contrast by using a smoothing function
available as part of the ION-TOF software.
2.5. Atomic force microscopy imaging
Topographical atomic force microscope (AFM) images were
obtained using a Nanoscope III scanning force multimode microscope
(Digital Instruments, Santa Barbara, CA). Samples were scanned in
contact mode in air within 2 hours of deposition. A silicon nitride
cantilever was used with a spring constant of 0.3 N/m and the scanner
was of the J type. Image analysis was performed using the Nanoscope
III software (version 5.12r3).
3. Results
3.1. Chemical imaging of a lipid mixture
In order to understand the properties of surfactant, studies have
been conducted utilizing mixtures of three of the most abundant PLs
present in pulmonary surfactant, DPPC, POPC and POPG. The phase
behavior of these types of mixture is well established, where lateral
pressure leads such monolayers to form “domains” where unsaturat-
ed PLs are generally present in the liquid expanded phase (LE) and the
saturated PLs are concentrated in the LC phase. This ﬁrst experiment
used these established properties of such a mixture to test the ability
of ToF-SIMS to determine the lateral distribution of these PLs in an LB
ﬁlm. In order to accomplish this, ions speciﬁc to each component must
be selected. These could be fragment ions or secondary ions of the
intact species. The ionization yield is low at the higher masses and
therefore, the contrast in the images of the molecular ions tends to be
poorer. In addition, these 3 PLs are chemically very similar and will
therefore fragment in a similar fashion. For example, all species shareFig. 1. ToF-SIMS (A–C) and AFM (D) images of a 50:30:20 d4-DPPC:POPC:d31-POPG ﬁlm comp
freshly cleavedmica (D)by conventional Langmuir–Blodgett deposition.MapsofpositiveSI showi
respectively. All ToF-SIMS images are50×50 μm2,256×256pixelswith1 shot/pixel. AFM image i
area indicated by the black box.the palmitic acid unit, two PLs share the phosphatidylcholine unit and
two share the oleic acid unit. To resolve this difﬁculty, deuterated
analogues are commonly used in ToF-SIMS experiments. It has been
shown that the incorporation of deuterium into the lipid chains does
not alter the miscibility or phase behaviour of these systems [32] and
also these deuterated analogues have the same fragmentation pattern
within a ToF-SIMS experiment [33]. Therefore, fragment ions from
deuterated analogues should easily be distinguished from those
arising from the isotopically unlabelled lipids by the difference in
masses.
Figs. 1A–C show representative ToF-SIMS images collected in
positive ion mode for an LB sample of 50:30:20 d4-DPPC:POPC:d31-
POPG compressed and deposited at a surface pressure of 30 mN/m.
The deuterium is located in the head group of DPPC and the acyl chain
of POPG. Under bombardment, these 3 PLs generate a large number of
ions from the head group and acyl chains; however, we successfully
chose 3 ions which unambiguously give the lateral distribution of
each component. Figs. 1A–C correspond to M50 (C3D7+) which is a
deuterated fragment from the acyl chain of d31-POPG, M184
(C5H15NPO4+) derived from the head group of POPC and M188
(C5H11D4NPO4+) speciﬁc to d4-DPPC, respectively. At this surface
pressure, phase separated domains form in the monolayer which
range in diameter from 2 to 10 μm. These data correlate well with
the known behaviour of this lipid mixture, with the unsaturated
PLs (POPC and d31-POPG) present mainly in the liquid expanded
phase (LE), and the saturated PL (d4-DPPC) concentrated in the LC
phase.
Atomic force microscopy (AFM) was also used to conﬁrm domain
formation. Fig. 1D shows a topographical image of a 50:30:20 d4-
DPPC:POPC:d31-POPG compressed to a surface pressure of 30 mN/m
and transferred onto mica by Langmuir–Blodgett technique. For AFM
imaging, we did not use gold-coated mica, which is the substrate used
in ToF-SIMS experiments because of interference from reﬂection. This
image shows that two types of LC domains form LC micro-domains
which have an average diameter of ~5 μm, similar to the domains seen
in the ToF-SIMS images in Figs. 1A–C and nano-domains with an
average diameter of ~100 nm. A zoomed-in AFM image is inserted in
Fig. 1D to clearly show the presence of nano-domains. We have
performed extensive height analysis of nano and micro-domains
(data not shown) andwe found their height difference to be similar at
~0.9 nm. Since their height analysis is similar, we conclude that their
lipid composition is likely similar. LC nano-domains are not resolved
by ToF-SIMS due to their size; however, they may explain the
presence of DPPC outside LC domains seen in Fig. 1C.
Lipid mixtures can be altered further to, for example, determine
the lateral distribution of cholesterol. In the second lipid mixture
experiment, we added 30 mol% of a deuterated analogue of
cholesterol (d7-cholesterol) to a PL mix of 50:30:20 DPPC:POPC:
POPG. Although 30 mol% is relatively high compared to previousressed to a surface pressure of 30 mN/m and transferred onto gold-coated mica (A–C) and
ng fragment ionsM50(A),M184(B)andM188(C) speciﬁc tod31-POPG,POPCandd4-DPPC,
s 60×60 μm2andthehighmagniﬁcationAFM image inserted showsazoomed-in viewof the
Fig. 2. ToF-SIMS images of 50:30:20 DPPC:POPC:POPG supplemented with 30 mol% d7-
cholesterol ﬁlm compressed to a surface pressure of 30 mN/m and transferred onto gold-
coated mica by conventional Langmuir–Blodgett deposition. Maps of negative SI showing
M2(A)which corresponds todeuteriumandgives the locationofd7-cholesterol andM255
(B) which corresponds to palmitate. Both images are 100×100 μm2, 256×256 pixelswith
1 shot/pixel.
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sufﬁcient contrast in ToF-SIMS images. Representative negative ion
mode images of an LB ﬁlm compressed to 30 mN/m are shown in
Figs. 2A and B. The image of palmitic acid (Fig. 2B) reveals the
presence of domains under these conditions. Fig. 2A shows the
distribution of deuterium and therefore the location of cholesterol
within domains as would be expected considering that the hydroxylic
group of cholesterol interacts preferentially with the head groups of
DPPC and DPPG [34].
3.2. Chemical imaging of an exogenous therapeutic surfactant—bovine
lipid extract surfactant (BLES)
Whereas imaging simple lipid mixtures, as described above, is
fairly straightforward especially when using deuterium analogues,
naturally derived exogenous surfactant preparations, such as bovine
lipid extract surfactant (BLES), are compositionally more complex and
are less well characterized in terms of phase separation. BLES is a
clinical surfactant used to treat neonatal respiratory distress syn-
drome (NRDS) developed by premature babies who do not have
sufﬁcient amounts of surfactant. Compositionally, BLES is well
characterized and consists of two surfactant associated proteins, SP-
B and SP-C, a low amount of cholesterol and a complex PL proﬁle that
includes DPPC, various other PC species, both disaturated andFig. 3. ToF-SIMS negative ion mode images of M2 (deuterium) for 3 LB ﬁlms: BLES+10 m
compressed and deposited at a surface pressure of 30 mN/m. Images A1–C1 were obtained
increase contrast. All images are 50×50 μm2, 256×256 pixels with 1 shot/pixel.unsaturated PG molecules as well as minor levels of other phospho-
lipids. Elucidating the lateral distribution of these various components
in BLES would enhance our understanding of how speciﬁc compo-
nents interact and possibly lead to a better understanding
of surfactant function mechanism. As mentioned in the previous
section, multiple components of pulmonary surfactant may fragment
in a similar fashion which makes the selection of speciﬁc ion
fragments very difﬁcult. Although BLES cannot be made up of solely
deuterium labeled lipids, samples can be modiﬁed by adding
cholesterol or spiked with small amounts of speciﬁc deuterated PLs
or 15N-labeled peptide, in order to enhance the detection of those
molecules.
To localize speciﬁc phospholipids in BLES, our third experiment
utilized BLES samples spiked with various lipids; the ﬁrst sample was
labeledwith 10 mol% d4-DPPC, the secondwith 5 mol% d31-POPC and
the third with 5 mol% d31-POPG. Figs. 3A–C show representative ToF-
SIMS images collected in negative ion mode. Each image shows the
lateral distribution of M2. All contributions to M2 in negative ion
mode are due to deuterium; therefore, these images show the lateral
distribution of d4-DPPC, d31-POPC and d31-POPG, respectively, in
the three different samples. The SI yield of M2 was low which can
be seen as low intensity. To improve the contrast and therefore
better visualize the location of PLs, the images were subjected to
a smoothing function available as a part of the ToF-SIMS software.
The resulting images, shown in Figs. 3A1–C1, show domain formation
due to phase separation with diameters ranging from 8 to 15 μm.
The d4-DPPC is concentrated in solid LC domains, while d31-POPC
is present in the ﬂuid LE phase. Interestingly, d31-POPG is mainly
present in the LE phase but in some cases shows an increased
concentration around the edges of LC domains.
In addition to lipids, BLES also contains hydrophobic proteins SP-B
and SP-C. Under bombardment by the primary beam of a ToF-SIMS
instrument, proteins have a characteristic fragmentation pattern
characteristic of the amino acid composition. Other ToF-SIMS studies
using reconstituted surfactant systems have deciphered typical SI
fragments corresponding to surfactant-associated proteins; however,
in more complex systems, such as a natural pulmonary surfactant,
signals arising from various lipids and proteins often show signiﬁcant
interference making it difﬁcult to determine their location. To avoid
this difﬁculty, we added a 15N-labeled peptide (miniB) to BLES and
determined its lateral distribution in an LB ﬁlm. miniB is a 34-residueol% d4-DPPC (A), BLES+10 mol% d31-POPC (B) and BLES+10 mol% d31-POPG (C)
by subjecting A–C to a smoothing function available as part of the ION-TOF software to
Fig. 5. ToF-SIMS images showing the effect of cholesterol on the lateral organization of
DPPC and DPPG in BLES LB ﬁlms. BLES was supplemented with 20 mol% cholesterol and
a ﬁlm was compressed to a surface pressure of 30 mN/m and transferred onto gold-
coated mica by conventional Langmuir–Blodgett technique. Image A was collected in
positive ion mode and shows the distribution of M735 (DPPC-H+) and image B was
collected in negative ion mode and shows the distribution of M722 (DPPG−). Both
images are 50×50 μm2, 256×256 pixels with 1 shot/pixel.
618 E. Keating et al. / Biochimica et Biophysica Acta 1808 (2011) 614–621peptidewith internal disulﬁde linkages that is composed of the N- and
C-terminal helical regions of SP-B. It has been shown to retain similar
activity to full-length SP-B in certain in vitro and in vivo studies [29].
Therefore, we expect miniB to be found in the same location as SP-B.
M45, corresponding to C2H615N+, was selected to unambiguously
determine the lateral distribution ofminiB in a BLES LBﬁlm compressed
to a surface pressure of 30 mN/m. Figs. 4A–D are ToF-SIMS images
collected inpositiveandnegative ionmodes and correspond toC2H615N+
(M45) fromminiB, palmitic acid (M255), DPPG−molecular ion (M722)
and POPG− parent ion (M747), respectively. Because the SI yield of
some of these ions was low, all images were subjected to a smoothing
function to improve contrast and therefore, more clearly show the
lateral distribution. The palmitic acid image clearly reveals the presence
of domains with diameter in the range of 2–8 μm. The saturated PL,
DPPG, is concentrated within these domains while the unsaturated PL,
POPG, is present outside domains. These results indicate that domain
formation is due to phase separation. Fig. 4A1 shows that the peptide,
miniB, is associated with the ﬂuid, LE phase.
In addition to determining the localization of speciﬁc components
within the surface ﬁlm, ToF-SIMS can also be utilized to examine
whether the distribution of one component is affected by the presence
of another. For example, it has been proposed that cholesterol can
modulate structural organization of a surface ﬁlm. Our lab has shown
that addition of physiological amounts of cholesterol toBLES leads to the
formation of domains within liquid condensed domains at low surface
pressure as well as an increase in the number of liquid condensed
domains and a decrease in their average diameter. The experiments
performed for Figs. 5 and 6 address this phenomenon by examining the
lateral distribution of PLs or of miniB after supplementing BLES with
cholesterol. 20 mol% cholesterol was added to BLES in the experiment
for Fig. 5. Fig. 5A corresponds to M735 which shows the distribution of
the DPPC-H+ molecular ion and Fig. 5B corresponds to M722 showing
the distribution of DPPG−molecular ion. These images unambiguously
show that DPPC and DPPG are still concentrated within domains.
Furthermore, DPPG seems to be heterogeneously distributed within
domains, separating perhaps within the third phase, Lo, induced by the
presence of cholesterol as suggested by previous studies.
To examine whether the distribution of miniB is affected by the
presence of cholesterol, we added 30 mol% d7-cholesterol to BLES in
the presence of 20 mol% 15N-miniB. ToF-SIMS images of such an LBFig. 4. ToF-SIMS images of a BLES LB ﬁlm supplemented with 20 mol% 15N-miniB com
by conventional Langmuir–Blodgett technique. A–D are SI maps showing the distribution o
(POPG−). Images shown in A1–D1 were obtained by subjecting A–D to a smoothing fun
50×50 μm2, 256×256 pixels with 1 shot/pixel.ﬁlm compressed to a surface pressure of 30 mN/m are shown in Fig. 6.
All images shown in Figs. 6 (A–E) were subjected to a smoothing
function to improve contrast and the resulting images are labeled as
A1–E1, respectively. The palmitic acid image (M255) shows the
formation of domains. Molecular ion images for DPPG− and POPG−
show that the saturated PL is present within domains while the
unsaturated PL is present outside domains. These results also indicate
that phase separation occurs under these conditions. Based on the
distribution of deuterium, we conclude that cholesterol is concen-
trated inside domains. It is known that in the presence of cholesterol,
Lo and LC phases exist and are seen as domains within condensed
domains. Unfortunately, due to low SI yield, it is difﬁcult to conclude
whether the distributions of DPPG and cholesterol are heterogeneous.
M45 (C2H615N+) was selected to show the location of miniB in the
ﬂuid, LE phase. This indicates that the distribution of the peptide is not
affected by the presence of cholesterol.
3.3. Chemical imaging of PLs in rat pulmonary surfactant
The ﬁnal experiment focused on utilizing ToF-SIMS for imaging a
natural surfactant. Lateral distribution of surfactant components
within the ﬁlms of natural surfactant would not only provide insightpressed to a surface pressure of 30 mN/m and transferred onto gold-coated mica
f M45 (C2H615N+) speciﬁc to 15N-miniB, M255 (palmitate), M722 (DPPG−) and M747
ction available as part of the ION-TOF software to increase contrast. All images are
Fig. 6. ToF-SIMS images showing the effect of cholesterol on the lateral distribution of miniB and PLs in BLES LB ﬁlms. BLES supplemented with 20 mol% 15N-miniB and 20 mol% d7-
cholesterol was compressed to a surface pressure of 30 mN/m and transferred onto gold-coated mica by conventional Langmuir–Blodgett technique. A–E were collected in positive
and negative ion modes and show the distribution of M2 (deuterium) speciﬁc to d7-cholesterol, M45 (C2H615N+) speciﬁc to 15N-miniB, M255 (palmitate), M722 (DPPG−) and M747
(POPG−), respectively. A1–E1 were obtained by subjecting A–E to a smoothing function available as part of the ION-TOF software to improve contrast. All images are 50×50 μm2,
256×256 pixels with 1 shot/pixel.
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correlate with physiological studies. In the current experiment, we
used natural surfactant which was lavaged from the lungs of rats
which were injured by mechanical ventilation with high tidal volume
Vt and from non-injured normal rats. Lung injury in the ventilated rats
was conﬁrmed by lowered blood oxygenation and reduced lung
compliance as previously reported in this experimental model [30]. In
addition, previous studies have also demonstrated that high Vt
mechanical ventilation leads to a change in the composition of
surfactant including an increase in cholesterol from 8% to 12% by
weight.
Representative ToF-SIMS images of rat surfactant LB ﬁlms com-
pressed to a surface pressure of 30 mN/m are shown in Fig. 7. TheFig. 7. ToF-SIMS images collected in positive (M735, DPPC-H+) and negative (M255, palmita
surfactant from non-injuriously ventilated (control) rats (A–C) and injuriously ventilated
pressure of 30 mN/m and transferred onto gold-coated mica by conventional Langmuir–Blopalmitic acid image of the control group clearly shows the presence of
domains as well as domains within domains. Saturated PLs, DPPC and
DPPG, are present in domains with a higher concentration in domains
within domains. The palmitic acid image of the injuriously ventilated
animal group also shows the presence of domains. We have previously
shown that at high enough cholesterol concentrations the percolation
threshold is crossed which leads to condensed domains fusing to give
large solid domains with ﬂuid phase areas trapped within [35]. This
effect can be seen in the top part of Fig. 7D which shows such a large
domain as well as micron-sized condensed domains. Fig. 7E and F
correspond to DPPC-H+ and DPPG−, respectively and they show that
these saturatedPLs are present in themicro-domains aswell as the large
domain “island.”te; M722, DPPG-) ion modes showing the lateral organization of LB ﬁlms of pulmonary
(2 hours high Vt ventilation) rats (D–F). Both samples were compressed to a surface
dgett transfer. Images are 50×50 μm2, 256×256 pixels and 1 shot/pixel.
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The objective of this paper was to present a wide range of
experiments to illustrate the applicability of ToF-SIMS for surfactant
research. Our results showed that ToF-SIMS could be utilized to
investigate the lateral organization of surfactant interfacial ﬁlms to
gain information about phase separation and location of various
components. By utilizing reconstituted lipid samples using deuterated
analogues, we demonstrated unambiguous localization of speciﬁc
lipids. Exogenous surfactant was used as a more complex model
system to illustrate features of natural surfactant and the inﬂuence of
added components on the lateral organization of speciﬁc components
such as SP-B and cholesterol. Finally, we demonstrated that ToF-SIMS
could provide lateral information on endogenous surfactant samples
obtained from two different physiological conditions. Overall, these
results support the concept of ToF-SIMS as a novel tool to enhance
surfactant research and help elucidate, for example, the role of
individual components in promoting lipid–lipid and lipid–protein
interactions within the surface ﬁlm and how these interactions are
affected by surfactant inhibition. Such information could prove useful
in furthering our understanding of surfactant function.
In order to fully comprehend the value of ToF-SIMS in surfactant
research, it is important to also understand the limitations of this
technique. As described in the Results, one of the limitations is the
chemical similarities between different PL molecules leading to
identical fragments from different molecules. In some experiments,
such as those with lipid mixtures and exogenous surfactant
preparation, this limitation can be resolved by including deuterium
labeled analogues.We are aware that the addition of small amounts of
deuterated components could perturb the phase equilibrium of a
mixture, particularly when probing for minor components such as
DPPG. In experiments in which the addition of deuterium analogues
could impact the properties of the surfactant itself, such as
endogenous surfactant from different physiological conditions,
principal component analysis (PCA) of ToF-SIMS data could be
performed to determine common localization of different compo-
nents [32]. Another limitation of ToF-SIMS that should be considered
when utilizing this technique is that the ionization/localization of
speciﬁc fragments is only semi-quantitative and matrix effects have
to be taken into consideration. Thus, although the fragments will
deﬁne the presence of that molecule in a speciﬁc position in the
surface ﬁlm, the intensity of the signal is only partly related to the
concentration of themolecule; other factorsmay inﬂuence the signal
intensity such as the phase that the molecule is in and the ionization
properties of the molecule. Despite these limitations, the ability of
ToF-SIMS to provide a chemical compositional map of a surfactant
ﬁlm could be a major asset in comparing surfactant ﬁlm component
organization, for example with functional and dysfunctional PS.
Currently, the major established techniques utilized in this area of
study are atomic force microscopy, captive bubble surfactometry,
ﬂuorescencemicroscopy and a variety of other techniques. ToF-SIMS
used in combination with these established approaches can add
important additional information on surfactant properties.
Whereas our overall goal was to provide examples of speciﬁc
experimental approaches to demonstrate the potential of the imaging
abilities of ToF-SIMS, some of the individual experiments provided
interesting results that warrant further discussion in the context of the
current surfactant literature. For example, an interestingﬁndingwas the
increased concentration of POPG around the edge of LC domains
observed in BLES samples spiked with deuterium-labeled POPG. The
implication of this ﬁnding is currently unknown but has been suggested
that the net positive charge of SP-B promotes electrostatic interactions
with the anionic PL fraction of surfactant, such as PG [33,36–38]. Surface
tension measurements withmodel surfactant samples support a strong
functional role for SP-B working in conjunction with anionic PL. Our
ﬁnding of an increased concentration of POPG around the edge ofcondensed domains may be due to such interaction between POPG and
SP-B. It should be noted, however, that we did not detect a similar
increased concentration of miniB around the condensed domains; the
low SI yield of ions speciﬁc for miniB may have limited the detection of
areas of higher concentrations within the LE phase. Further studies
utilizing ToF-SIMS are required andmay provide direct evidence for the
interaction of SP-B with POPG or other anionic PL.
A second set of speciﬁc ﬁndings worthy of further discussion relate
to experiments in which cholesterol levels were altered. Considerable
research has been devoted toward understanding the role of cholesterol
in PS [35,39,40]. Since endogenous levels of about 5%–10% appear to be
present in most mammalian surfactants, it has been suggested that this
neutral lipid is important for function. Cholesterol may assist in
adsorption/reinsertion of lipids to the air–liquid interface although
this should be investigated further. Stronger evidence exists for the
notion that elevated cholesterol leads to surfactant dysfunction. For
example, adding supraphysiological amounts of cholesterol to exoge-
nous surfactant preparations inhibits surfactant function [35,41–43] and
lateral organization [35,44,45].
With respect to physiological levels of cholesterol, we utilized ToF-
SIMS to make two observations. First, we showed that physiological
amount of cholesterol in BLES did not affect the location of PLs orminiB,
a peptide with similar surface activity as SP-B. More speciﬁcally, we
show that saturated PLs remain concentrated in LC domains while
unsaturated PLs and miniB are almost exclusively detected in the ﬂuid,
LE phase. These ﬁndings are in agreement with studies, utilizing a
variety of other techniques, which have reported that SP-B distributes
preferentially in disordered regions of membranes [39] and interfacial
ﬁlms [38]. Second, we observed that addition of physiological amounts
of cholesterol to BLES leads to a heterogeneous distribution of DPPG
within condensed domains. We have previously reported that the
presence of physiological amount of cholesterol in BLES induces the
formation of a newphase, Lo,within condenseddomains, as determined
by AFM [35]. Based on the ToF-SIMS results, it is possible to speculate
that cholesterol interactswithDPPC such that segregation occurswithin
the solid domainswhere DPPC and DPPG are no longermiscible leading
to regions highly concentrated in DPPG. Our data that cholesterol, when
added at high physiological levels to our 3 PL mixture, was detected
within condensed domains provide further support for this possible
interaction with DPPC.
Effect of elevated cholesterol has been observed in the experiments
using normal and injured animals. Compositional studies show a
signiﬁcant increase in the amount of cholesterol found in the PS of these
injuriously ventilated rats compared to control. Although this increase
in the level of cholesterol is believed to be a main culprit in surfactant
dysfunction, we cannot exclude other compositional alterations being
responsible for the observed effects. Nevertheless, we showed that the
injured, high cholesterol, sample had large solid domains with ﬂuid
phase trapped within. It is likely that due to high cholesterol the
percolation threshold is crossed causing LC domains to fuse. This is in
agreement with our previous AFM studies of supraphysiological levels
of cholesterol in BLES [35]; however, further experiments are required
to provide more evidence for this speculation.
In conclusion, we show that we can successfully determine the
lateral organization of surfactant interfacial ﬁlms using systems
varying in complexity, from PL mixtures to endogenous surfactant
to natural surfactant. We show that we can detect phase separation
and determine the location of PLs, cholesterol and miniB. This enables
us to better understand lipid–lipid interactions, such as DPPC and
cholesterol, and lipid–protein interactions, such as POPG and SP-B.
Also, by studying systems with physiological levels of cholesterol, we
can understand the role it plays in modulating the structure of
surfactant ﬁlms. Studying surfactant systems with supraphysiological
levels of cholesterol, such as surfactant from injuriously ventilated
rats, provides information regarding the role that cholesterol plays
in surfactant dysfunction. These types of ToF-SIMS experiments
621E. Keating et al. / Biochimica et Biophysica Acta 1808 (2011) 614–621complement very well other methodologies used in surfactant
research, such as AFM, ﬂuorescence microscopy, EM, captive bubble
tensiometry and others. As more information regarding surfactant
function is gathered using these complementary approaches, the
insight gained should prove useful in understanding the mechanisms
associated with surfactant dysfunction which may lead to preparation
of more effective therapeutic surfactants.Acknowledgments
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